logo
Indian-origin tech CEO Harshavardhana Kikkeri, wife and 14-year-old son found dead at Newcastle home

Indian-origin tech CEO Harshavardhana Kikkeri, wife and 14-year-old son found dead at Newcastle home

Hindustan Times29-04-2025
A 57-year-old Indian-origin tech entrepreneur from Mysuru was found dead along with his wife and son in Washington's Newcastle last week, Deccan Herald reported. CEO of HoloWorld, a robotics company headquartered in Mysuru, Harshavardhana S Kikkeri was found dead along with his wife and co-founder Shwetha Panyam, 44, and their 14-year-old son, identified as Dhruva Kikkeri by Seattle Times.
Police responded to a 911 call last week at a townhouse in King County where they found blood on a window and a bullet in the street along with three bodies, King County sheriff's spokesperson Brandyn Hull told Seattle Times.
Police have not revealed the motive behind the crime and refused to comment on whether it was a case of murder-suicide. However, the medical examiner's office classified Shwetha and Dhruva's death as homicides and stated that Harshavardhana died by suicide, according to Seattle Times.
Neighbours said the family of four kept to themselves and lived in the townhouse, with the couple's younger son 7, being the only survivor.
Tech entrepreneur Harshavardhana Kikkeri hailed from Manya's Kikkeri village and studied in Mysuru and US, Deccan Herald reported. He held a Masters degree in Electrical Engineering from Syracuse University and had worked with Microsoft, specialising in robotics.
In 2017, he returned to India and co-founded HoloWorld with his wife Shwetha. The company ended operations in 2022, as per Indian Express, however, its social media accounts were last updated in November 2023.
Kikkeri and his family went back to US in 2022. He made headlines for creating HoloSuit – an AI enabled full body motion capture suit which acts as a virtual trainer for your body.
According to the description of a TedX talk by Kikkeri on YouTube, he won numerous leadership awards including Gold Star from Microsoft, Excellence Award from Infosys, Bharat Petroleum Scholarship and several chess tournaments.
The video description also claimed that he held 44 international patents from the US, Europe, China, Japan among others.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Indian shares inch lower as Kotak earnings drag financials, trade deal delay weighs
Indian shares inch lower as Kotak earnings drag financials, trade deal delay weighs

Mint

time8 minutes ago

  • Mint

Indian shares inch lower as Kotak earnings drag financials, trade deal delay weighs

By Bharath Rajeswaran and Vivek Kumar M (Reuters) -Indian shares inched lower on Monday as weak results from Kotak Mahindra Bank weighed on sentiment, while uncertainty over trade talks with the U.S. added to overall caution. The Nifty 50 fell 0.16% to 24,798.9 points and the BSE Sensex lost 0.2% to 81,325.4 as of 10:03 a.m. IST. The broader small-caps and mid-caps lost 0.3% and 0.2%, respectively. Negotiations between India and the United States remained deadlocked over tariff cuts on agriculture and dairy products, dimming hopes of an interim deal ahead of U.S. President Donald Trump's August 1 deadline. This is in contrast to a framework trade agreement struck between the U.S. and European Union over the weekend, easing fears of a bigger trade war between the two allies, which account for almost a third of global trade. High-weightage financials and private banks lost 0.2% and 1%, respectively, dragged by a 7% fall in Kotak Mahindra Bank after it posted a drop in quarterly profit. The IT index lost 0.5%, with Tata Consultancy Services shedding 1.6% after it announced plans to reduce its workforce by 2% in fiscal year 2026. The Nifty 50 and 30-stock Sensex have logged four consecutive weekly losses due to weak earnings, foreign outflows and uncertainty over the U.S.-India trade deal. "A dull earnings season and the lingering delay in the India-U.S. trade deal have clearly cast a shadow on market sentiment. With valuations still stretched across the board, investors are understandably treading with heightened caution," said G Chokkalingam, founder and head of research at Equinomics Research. Among individual stocks, Mphasis gained 2.4% on posting quarterly results in-line with estimates and on strong deal bookings, which has boosted the IT company's revenue growth outlook. SBI Cards and Payment Services lost 3.7% after missing profit estimates in the June quarter. (Reporting by Vivek Kumar M and Bharath Rajeswaran; Editing by Eileen Soreng and Mrigank Dhaniwala)

Market in consolidation mode; triggers needed, says Sunil Subramaniam
Market in consolidation mode; triggers needed, says Sunil Subramaniam

Economic Times

time8 minutes ago

  • Economic Times

Market in consolidation mode; triggers needed, says Sunil Subramaniam

Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads "Another reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped sentiment," says Sunil Subramaniam , Market like you said, the question is—why were they under pressure in the first place? I'd call it the Trump effect. Mr. Trump has been talking a lot about imposing heavy pharma tariffs. He hasn't actually done anything yet, but every time he makes such statements, it creates nervousness—whether he's targeting CDMO players or generics, and how he plans to go about it. That uncertainty has impacted the pharma sector, putting it under when individual companies are reporting good numbers, the market has no choice but to buy into them—because at least those companies are indicating a positive outlook. Plus, some of them may not even be impacted by tariffs, creating a window of opportunity. Also, the pharma space includes domestic-oriented businesses like hospitals and diagnostics, which are unaffected by U.S. tariff issues. So overall, pharma remains a defensive reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped we need to understand the market's movement over the last three months. Post-March, FIIs were actually buyers in April and May, and even in June, though to a lesser extent. Meanwhile, if you look at the end of March, mutual fund DIIs—especially domestic mutual funds—had built up cash positions to around 7.25% of their April and May, both mutual funds and FIIs were buying, which supported the market. But starting this month, mutual fund cash levels are back down to around 5%, which is close to their lower limit. That means DIIs don't have as much cash left to deploy, apart from the fresh SIP looking at last earnings season and market levels, domestic funds have largely deployed their cash. FIIs, on the other hand, had expected some action around the BTA by July 9, which then got pushed to August 1. But now, even that deadline seems unlikely to be met. The Indian trade delegation has returned from the U.S. without a deal. Sticking points remain—like agriculture—and they won't be easy to the question now is whether Trump will extend the 10% tariff pause beyond August 1 or slap a 26% tariff on India and then negotiate, like he did with Japan—imposing higher tariffs first and then signing a deal at 19%. That kind of uncertainty around the India-U.S. BTA is keeping FIIs factor is China. While China and the U.S. haven't signed a full BTA either, they seem to have reached some understanding. Meanwhile, China's markets have been beaten down so much that the one-year forward P/E is around 11—compared to India's 22. And China's economy is about 4.5 times larger than India's. Even at 4% growth, those are big numbers. So FIIs are starting to see more value in China, pulling some attention away from as for your question on the next trigger—clearly, a breakthrough on the BTA front, like an interim deal or assurance that tariffs will be capped below 20%, could bring FIIs back. On the domestic side, it's the ongoing earnings season. Results have been mixed. The IT sector, for instance, didn't post terrible earnings, but weak guidance is weighing heavily, especially in the absence of FII DIIs have already used most of their cash, their incremental buying will depend on the inflow from SIPs and earnings results. So companies with strong earnings and forward guidance will likely get DII if the early festival season gives good signs on the consumption front, that could also be a positive trigger. Until then, expect the market to remain in a sideways, consolidative phase for some time.

India bonds may continue to see selling pressure at start of week
India bonds may continue to see selling pressure at start of week

Economic Times

time8 minutes ago

  • Economic Times

India bonds may continue to see selling pressure at start of week

Indian government bonds are likely to see persistent selling pressure in early deals on Monday, as sentiment remains cautious after the benchmark bond yield rose above a key level in the previous session. ADVERTISEMENT The yield on the benchmark 10-year bond is likely to move between 6.33% and 6.37%, a trader at a private bank said, after closing at 6.3505% on Friday - the highest level since May 9. "Traders are losing interest and not building fresh positions, and hence we witnessed a large selloff after the debt auction on Friday," the trader said. The Reserve Bank of India sold 300 billion rupees ($3.47 billion) of the benchmark 2035 bond on Friday, the cutoff for which was in line with estimates, but the note witnessed selling pressure after the result was announced. Selling was exacerbated after the RBI governor's comments curbed expectations for rate easing, prompting those who were betting on an August cut to pare positions. ADVERTISEMENT Sanjay Malhotra said monetary policy, being forward-looking, will place greater focus on the outlook for growth and inflation, rather than their current levels, when the policy panel meets on August 6. Malhotra added that the bar for further easing is higher than it would have been if the stance was accommodative, though the RBI still has the flexibility to move the rates up, down or pause. ADVERTISEMENT A plunge in India's retail inflation to a more than six-year low and expectations that it will slip to a record low in July have led to increased talk of a rate cut in August. ADVERTISEMENT India's overnight index swap rates rose on Friday, as market participants trimmed rate cut bets for next week. The one-year OIS rate ended at 5.53% on Friday and the two-year OIS rate ended at 5.51%. The liquid five-year OIS rate settled at 5.73%. KEY INDICATORS: ** Benchmark Brent crude futures were 0.4% higher at $68.70 per barrel after easing 1.1% in the previous session ** Ten-year U.S. Treasury yield at 4.3938%; two-year yield at 3.9296% ($1 = 86.4750 Indian rupees). (You can now subscribe to our ETMarkets WhatsApp channel)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store